Multiple healthcare stocks experienced significant pre-market price movements, with some companies seeing notable gains while others faced declines.

Multiple companies are exploring strategic options including potential mergers, acquisitions, and restructuring, with some facing financial challenges like bankruptcy and operational reviews.

The age-related macular degeneration (AMD) market is expected to grow due to the launch of new therapies and increased healthcare spending. Dry AMD and wet AMD are the two main types, with new treatments in development for both.

Clearside Biomedical is hosting a virtual key opinion leader (KOL) event on suprachoroidal drug delivery, focusing on its potential in treating neovascular age-related macular degeneration (wet AMD) and ongoing clinical programs.

- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET -